Se încarcă compania
Just reported
Q3 2026 results
From Baxter International's results release of 29 octombrie 2026; its quarterly report has since been filed.
Revenue
Actual
2,98B USD
+5,0 % y/y
+0,5 % q/qGuided
—
No guide given
EPS, GAAP
Actual
0,57 USD
+138 % q/q
Guided
—
No guide given
Operating income, GAAP
Actual
225M USD
+31 % y/y
+3,7 % q/qGuided
—
No guide given
Company outlook
Full year 2026
- EPS, adjusted2,05 USD – 2,15 USDRaised +2,4 %
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Keep exploring
The themes Baxter International is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Medical Instruments and Supplies
Graded A or B and worth $2B or more: A first, then the largest.
ISRGIntuitive Surgical, Inc.152,5B USDA+
MDLNMedline Inc.52,6B USDA
ALCAlcon Inc.35B USDA
BLCOBausch & Lomb Corp7,6B USDA-
ATRCAtriCure, Inc.2,9B USDA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 oct. 2026CBGraded C, now B
MCKMckesson Corporation4 nov. 2026BAGraded B, now A
CVSCVS Health Corp4 nov. 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 nov. 2026BAGraded B, now A
BIIBBiogen Inc.28 oct. 2026BAGraded B, now A
Situațiile financiare complete →
Construit din raportările proprii ale Baxter International Inc. la Comisia pentru Valori Mobiliare și Burse a SUA (SEC). Cifrele sunt cele raportate, iar istoricul pe acțiune este recalculat la baza de acțiuni de azi. Aceasta descrie o afacere — nu este consultanță de investiții și nu este o recomandare de cumpărare sau vânzare.
